Form 4: Novo Holdings A/S Sells 1,912,316 Shares of Spruce Biosciences, INC.
SEC Form 4 Filing
Novo Holdings A/S, a 10% owner of Spruce Biosciences, INC., sold 1,912,316 shares of common stock at an average price of $0.8884 on March 14, 2024.
Summary
- On March 14, 2024, Novo Holdings A/S sold 1,912,316 shares of Spruce Biosciences, INC. common stock.
- The shares were sold at a weighted average price of $0.8884.
- The price range for the sales was between $0.78 and $1.08.
- Following the transaction, Novo Holdings A/S beneficially owns 4,810,020 shares of Spruce Biosciences, INC. common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The sale itself could be interpreted in various ways, but the filing is purely factual.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders or major shareholders of a publicly traded company buy or sell the company's stock. This filing indicates a change in Novo Holdings A/S's ownership stake in Spruce Biosciences, INC.
Stakeholder Impact
- Shareholders may react to the news of a large shareholder selling a significant number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/14/2024 | Date of transaction: Novo Holdings A/S sold shares of Spruce Biosciences, INC. |
| 03/18/2024 | Date of signature: Form 4 signed by Barbara Fiorini Due, General Counsel, Finance & Operations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.